Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD

World Journal of Biological Psychiatry

Volumn 13, Issue 5, 2012, Pages 379-400

  Thome, Johannes ^a,b   Ehlis, Ann Christine ^c   Fallgatter, Andreas J ^c   Krauel, Kerstin ^d   Lange, Klaus W ^e   Riederer, Peter ^f   Romanos, Marcel ^g   Taurines, Regina ^f   Tucha, Oliver ^h   Uzbekov, Marat ⁱ   Gerlach, Manfred ^f  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f UNIVERSITY OF WÜRZBURG   (Germany)

^g UNIVERSITY OF MUNICH   (Germany)

^h UNIVERSITY OF GRONINGEN   (Netherlands)

ⁱ Research Institute of Psychiatry   (Russian Federation)

Author keywords

attentention defi cit hyperactivity disorder; Biomarker; neuroimaging; olfaction; proteomics; transcranial echosonography

Indexed keywords

ADRENALIN; BIOLOGICAL MARKER; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; NORADRENALIN; PROTEOME; SEROTONIN; TRYPTOPHAN;

ADRENALIN URINE LEVEL; AGE; AMINO ACID BLOOD LEVEL; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BRAIN ELECTROPHYSIOLOGY; COMORBIDITY; CONSENSUS DEVELOPMENT; DISEASE MARKER; DOPAMINE URINE LEVEL; ECHOGRAPHY; ELECTROENCEPHALOGRAPHY; EVENT RELATED POTENTIAL; EXECUTIVE FUNCTION; GENETIC ASSOCIATION; GENETIC LINKAGE; HEALTH CARE ORGANIZATION; HUMAN; INHIBITION (PSYCHOLOGY); LANGUAGE; MEDICAL LITERATURE; MEMORY; NEAR INFRARED SPECTROSCOPY; NEUROIMAGING; NORADRENALIN URINE LEVEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BLOOD LEVEL; PSYCHOPHARMACOTHERAPY; SENSITIVITY AND SPECIFICITY; SMELLING; SPATIAL DISCRIMINATION; URINALYSIS;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIOLOGICAL MARKERS; EVOKED POTENTIALS; HUMANS; NEUROIMAGING;

EID: 84864405643     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2012.690535     Document Type: Article

References (238)

1. Aebersold R, Mann M. 2003. Mass spectrometry-based proteomics. Nature 422:198-207.
2. Anderzhanova EA, Rayevsky KS, Saransaari P, Riitamaa E, Oja SS. 2001. Effects of sydnocarb and d-amphetamine on the extracellular levels of amino acids in the rat caudate-putamen. Eur J Pharmacol 428:87-95.
3. Albayrak Ö, Friedel S, Schimmelmann BG, Hinney A, Hebebrand J. 2008. Genetic aspects in attention deficit/hyperactivity disorder. J Neural Transm 115:305-316.
4. Albrecht J, Wiesmann M. 2006. The human olfactory system. Anatomy and physiology. Der Nervenarzt 77:931-939.
5. Aman CJ, Roberts RJ Jr, Pennington BF. 1998. A neuropsychological examination of the underlying deficit in attention deficit hyperactivity disorder: frontal lobe versus right parietal lobe theories. Dev Psychol 34:956-969.
6. American Psychiatric Association. 1992. Diagnostic and statistical manual of mental disorders. 4th ed. Text Revision. Washington, DC: American Psychiatric Association.
7. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington: APA.
8. Antshel KM, Faraone SV, Maglione K, Doyle AE, Fried R, Seidman LJ, Biederman J. 2010. Executive functioning in high-IQ adults with ADHD. Psychol Med 40:1909-1918.
9. Askenazy F, Caci H, Myquel M, Darcourt G, Lecrubier Y. 2000. Relationship between impulsivity and platelet serotonin content in adolescents. Psychiatr Res 94:19-28.
10. Atanasova B, Graux J, El Hage W, Hommet C, Camus V, Belzung C. 2008. Olfaction: a potential cognitive marker of psychiatric disorders. Neurosci Biobehav Rev 32:1315-1325.
11. Baehne CG, Ehlis AC, Plichta MM, Conzelmann A, Pauli P, Jacob C, et al. 2009. Tph2 gene variants modulate response control processes in adult ADHD patients and healthy individuals . Mol Psychiatry 14:1032-1039.
12. Baker GB, Bornstein RA, Douglass AB, Van Muyden JC, Ashton S, Bazylewich TL. 1993. Urinary excretion of MHPG and normetanephrine in attention deficit hyperactivity disorder. Mol Chem Neuropathol 18:173-178.
13. Barkley RA. 2006. Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment. New York: Guilford Press.
14. Barnett R, Maruff P, Purcell R, Wainwright K, Kyrios M, Brewer W, Pantelis C. 1999. Impairment of olfactory identification in obsessive-compulsive disorder. Psychol Med 29:1227-1233.
15. Barnett R, Maruff P, Vance A. 2005. An investigation of visuospatial memory impairment in children with attention deficit hyperactivity disorder (ADHD), combined type. Psychol Med 35:1433-1443.
16. Barry RJ, Clarke AR, Johnstone SJ. 2003. A review of electrophysiology in attention-deficit/hyperactivity disorder: I. Qualitative and quantitative electroencephalography. Clin Neurophysiol 114:171-183.
17. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K. 1995. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 45:182-184.
18. Behnke S, Schroeder U, Dillmann U, Buchholz HG, Schreckenberger M, Fuss G, et al. 2009. Hyperechogenicity of the substantia nigra in healthy controls is related to MRI changes and to neuronal loss as determined by F-Dopa PET. Neuroimage 47:1237-1243.
19. Bennetto L, Kuschner ES, Hyman SL. 2007. Olfaction and taste processing in autism. Biol Psychiatry 62:1015-1021.
20. Benson DF. 1991. The role of frontal dysfunction in attention deficit hyperactivity disorder. J Child Neurol 6:S9-12.
21. Berendse HW, Ponsen MM. 2006. Detection of preclinical Parkinson's disease along the olfactory trac(t). J Neural Transm Suppl 70:321-325.
22. Berendse HW, Ponsen MM. 2009. Diagnosing premotor Parkinson's disease using a two-step approach combining olfactory testing and DAT SPECT imaging. Parkinsonism Rel Disord 15(Suppl 3):S26-30.
23. Berg D, Becker G, Zeiler B, Tucha O, Hofmann E, Preier M, et al. 1999. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 53:1026-1031.
24. Berg D, Siefker C, Becker G. 2001a. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 248:684-689.
25. Berg D, Jabs B, Merschdorf U, Beckmann H, Becker G. 2001b. Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry 50:463-467.
26. Berg D, Roggendorf W, Schroder U, Klein R, Tatschner T, Benz P, et al. 2002. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59:999-1005.
27. Berg D, Godau J, Walter U. 2008. Transcranial sonography in movement disorders. Lancet Neurol 7:1044-1055.
28. Berk LE, Landau S. 1993. Private speech of learning disabled and normally achieving children in classroom academic and laboratory contexts. Child Dev 64:556-571.
29. Biederman J, Faraone SV. 2005. Attention-deficit hyperactivity disorder. Lancet 366:237-248.
30. Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA, et al. 1993. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 150:1792-1798.
31. Biederman J, Faraone SV, Spencer T, Wilens T, Mick E, Lapey KA. 1994. Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Res 53:13-29.
32. Biomarkers Definitions Working Group. 2001. Biomarkers and surrogate endpoints preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89-95.
33. Boucugnani LL, Jones RW. 1989. Behaviors analogous to frontal lobe dysfunction in children with attention deficit hyperactivity disorder. Arch Clin Neuropsychol 4:161-173.
34. Borta A, Höglinger GU. 2007. Dopamine and adult neurogenesis. J Neurochem 100:587-595.
35. Brand G. 2006. Olfactory/trigeminal interactions in nasal chemoreception. Neurosci Biobehav Rev 30:908-917.
36. Brown GG, Mathalon DH, Stern H, Ford J, Mueller B, Greve DN, et al. 2011. Multisite reliability of cognitive BOLD data. Neuroimage 54:2163-2175.
37. Bruce B, Thernlund G, Nettelbladt U. 2006. ADHD and language impairment: A study of the parent questionnaire FTF (Five to Fifteen). Eur Child Adolesc Psychiatry 15:52-60.
38. Buitelaar J, Rothenberger A. 2004. Foreword-ADHD in the political and scientific context. Eur Child Adolesc Psychiatry 13:1-6.
39. Campbell M, Spencer EK. 1988. Psychopharmacology in children and adolescent psychiatry: A review of the past five years. J Am Acad Child Adolesc Psychiatry 27:269-279.
40. Cao Q, Zang Y, Zhu C, Cao X, Sun L, Zhou X, Wang Y. 2008. Alerting deficits in children with attention deficit/hyperactivity disorder: event-related fMRI evidence. Brain Res 1219:159-168.
41. Casey BJ, Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Schubert AB, et al. 1997. Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 36:374-383.
42. Casey BJ, Epstein JN, Buhle J, Liston C, Davidson MC, Tonev ST, et al. 2007. Frontostriatal connectivity and its role in cognitive control in parent-child dyads with ADHD. Am J Psychiatry 164:1729-1736.
43. Castellanos FX, Tannock R. 2002. Neuroscience of attentiondeficit/ hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 3:617-628.
44. Castellanos FX, Elia J, Kruesi MJ, Gulotta CS, Mefford IN, Potter WZ, et al. 1994. Cerebrospinal fl uid monoamine metabolites in boys with attention-deficit hyperactivity disorder. Psychiatry Res 52:305-316.
45. Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Vaituzis AC, Dickstein DP, et al. 1996. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53:607-616.
46. Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, et al. 2002. Developmental trajectories of brain volume abnormalities in children and adolescents with attention deficit/hyperactivity disorder. J Am Med Assoc 288:1740-1748.
47. Castellanos FX, Kelly C, Milham MP. 2009. The restless brain: attention-deficit hyperactivity disorder, resting-state functional connectivity, and intrasubject variability. Can J Psychiatry 54:665-672.
48. Cherkasova MV, Hechtman L. 2009. Neuroimaging in attentiondeficit hyperactivity disorder: beyond the frontostriatal circuitry. Can J Psychiatry 54:651-664.
49. Cleland TA, Sethupathy P. 2006. Non-topographical contrast enhancement in the olfactory bulb. BMC neuroscience 7:7.
50. Cohen RA. 1993. The neuropsychology of attention. New York: Plenum Press.
51. Conner AC, Kissling C, Hodges E, H ü nnerkopf R, Clement RM, Dudley E, et al. 2008. Neurotrophic factor-related gene polymorphisms and adult attention deficit hyperactivity disorder (ADHD) score in a high-risk male population. Am J Med Genet B Neuropsychiatr Genet 147B:1476-1480.
52. Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL. 1995. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56:993-998.
53. Corkum PV, Siegel LS. 1993. Is the Continuous Performance Task a valuable research tool for use with children with attention-deficit-hyperactivity disorder? J Child Psychol Psychiatry 34:1217-1239.
54. Crosbie J, Perusse D, Barr CL, Schachar RJ. 2008. Validating psychiatric endophenotypes: inhibitory control and attention deficit hyperactivity disorder. Neurosci Biobehav Rev 32: 40-55.
55. Daselaar SM, Prince SE, Cabeza R. 2004. When less means more: deactivations during encoding that predict subsequent memory. NeuroImage 23:921-927.
56. Doyle AE, Faraone SV, Seidman LJ, Willcutt EG, Nigg JT, Waldman ID, et al. 2005. Are endophenotypes based on measures of executive functions useful for molecular genetic studies of ADHD? J Child Psychol Psychiatry 46:774-803.
57. Dresler T, Ehlis AC, Heinzel S, Renner TJ, Reif A, Baehne CG, et al. 2010. Dopamine transporter (SLC6A3) genotype impacts neurophysiological correlates of cognitive response control in an adult sample of patients with ADHD. Neuropsychopharmacology 35:2193-2202.
58. Durany N, Thome J, Palomo A, Foley P, Riederer P, Cruz-Sanchez FF. 1996. Homozygosity at the dopamine D3 receptor gene in schizophrenic patients. Neurosci Lett 220:151-154.
59. Durston S, Mulder M, Casey BJ, Ziermans T, van Engeland H. 2006. Activation in ventral prefrontal cortex is sensitive to genetic vulnerability for attention-deficit hyperactivity disorder. Biol Psychiatry 60:1062-1070.
60. Dvorakova M, Jezova D, Blazicek P, Trebaticka J, Skodacek I, Suba J, et al. 2007. Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): Modulation by a polyphenolic extract from pine bark (pycnogenol). Nutr Neurosci 10:151-157.
61. Ehlis AC, Baehne CG, Jacob CP, Herrmann MJ, Fallgatter AJ. 2008. Reduced lateral prefrontal activation in adult patients with attention-deficit/ hyperactivity disorder (ADHD) during a working memory task: a functional near-infrared spectroscopy (fNIRS) study. J Psychiatr Res 42:1060-1067.
62. Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Jons PH, Cohen DJ. 1999. High midbrain 18FDOPA accumulation in children with attention deficit hyperactivity disorder. Am J Psychiatry 156:1209-1215.
63. Fallgatter AJ. 2001. Electrophysiology of the prefrontal cortex in healthy controls and schizophrenic patients: a review. J Neural Transm 108:679-694.
64. Fallgatter AJ, Brandeis D, Strik WK. 1997. A robust assessment of the NoGo-anteriorisation of P300 microstates in a cued Continuous Performance Test. Brain Topogr 9:295-302.
65. Fallgatter AJ, Jatzke S, Bartsch AJ, Hamelbeck B, Lesch KP. 1999. Serotonin transporter promoter polymorphism infl uences topography of inhibitory motor control. Int J Neuropsychopharmacol 2:115-120.
66. Fallgatter AJ, Bartsch AJ, Herrmann MJ. 2002. Electrophysiological measurements of anterior cingulate cortex function. J Neural Transm 109:977-988.
67. Fallgatter AJ, Ehlis AC, Seifert J, Strik WK, Scheuerpfl ug P, Zillessen KE, et al. 2004. Altered response control and anterior cingulate function in attention-deficit/hyperactivity disorder boys. Clin Neurophysiol 115:973-981.
68. Fallgatter AJ, Ehlis AC, Rosler M, Strik WK, Blocher D, Herrmann MJ. 2005. Diminished prefrontal brain function in adults with psychopathology in childhood related to attention deficit hyperactivity disorder. Psychiatry Res 138:157-169.
69. Faraone SV. 2005. The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder. Eur Child Adolesc Psychiatry:1-10.
70. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. 2005. Molecular genetics of attentiondeficit/hyperactivity disorder. Biol Psychiatry 57:1313-1323.
71. Ferguson HB, Pappas BA, Trites RL, Peters DA, Taub H. 1981. Plasma free and total tryptophan, blood serotonin, and the hyperactivity syndrome: no evidence for the serotonin deficiency hypothesis. Biol Psychiatry 16:231-238.
72. Filipek PA, Semrud-Clikeman M, Steingard RJ, Renshaw PF, Kennedy DN, Biederman J. 1997. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 48:589-601.
73. Forssberg H, Fernell E, Waters S, Waters N, Tedroff J. 2006. Altered pattern of brain dopamine synthesis in male adolescents with attention deficit hyperactivity disorder. Behav Brain Funct 2:40.
74. Frank RA, Galasko D, Hampel H, Hardy J, de Leon MJ, Mehta PD, et al. 2003. Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the Biological Markers Working Group; NIA initiative on neuroimaging in Alzheimer's disease. Neurobiol Aging 24:521-536.
75. Franke B, Hoogman M, Arias Vasquez A, Heister JG, Savelkoul PJ, Naber M, et al. 2008. Association of the dopamine transporter (SLC6A3/DAT1) gene 9-6 haplotype with adult ADHD. Am J Med Genet B Neuropsychiatr Genet 147:1576-1579.
76. Franke B, Arias Vasquez A, Johansson S, Hoogman M, Romanos J, Boreatti-H ü mmer A, et al. 2010. Meta-analysis of the SLC6A3/DAT1 VNTR haplotype in adult ADHD suggests differential involvement of the gene in adult and childhood ADHD. Neuropsychopharmacology 35:656-664.
77. Frazier TW, Demaree HA, Youngstrom EA. 2004. Meta-analysis of intellectual and neuropsychological test performance in attentiondeficit/ hyperactivity disorder. Neuropsychology 18:543-555.
78. Freitag CM, Rohde L, Lempp T, Romanos M. 2010. Phenotypic and measurement infl uences on heritability estimates in childhood ADHD. Eur Child Adolesc Psychiatry 19:311-323.
79. Gainetdinov RR. 2010. Strengths and limitations of genetic models of ADHD. Attent Defic Hyperact Disord 2:21-30.
80. Gansler DA, Fucetola R, Krengel M, Stetson S, Zimering R, Makary C. 1998. Are there cognitive subtypes in adult attention deficit/hyperactivity disorder?. J Nerv Ment Dis 186:776-81.
81. Gau SS, Shang CY. 2010. Executive functions as endophenotypes in ADHD: evidence from the Cambridge Neuropsychological Test Battery (CANTAB). J Child Psychol Psychiatry 51: 838-849.
82. Gerlach M, Deckert J, Rothenberger A, Warnke A. 2008a. Editorial. Pathogenesis and pathophysiology of attention-deficit/hyperactivity disorder: from childhood to adult. J Neural Transm 115:151-153.
83. Gerlach M, Hendrich A, Hueber R, Jost W, Winkler J, Woitalla D, et al. 2008b. The early detection of Parkinson ́ s disease: unmet needs. Neurodeg Dis 5:137-139.
84. Giedd JN, Rapoport JL. 2010. Structural MRI of pediatric brain development: what have we learned and where are we going? Neuron 67:728-734.
85. Giedd JN, Lenroot RK, Shaw P, Lalonde F, Celano M, White S, et al. 2008. Trajectories of anatomic brain development as a phenotype. Novartis Found Symp 289:101-112; discussion 112-108, 193-105.
86. Gillberg C, Gillberg IC, Rasmussin P, KadesjöB, Söderström H, Rastam M, et al. 2004. Co-existing disorders in ADHD-implications for diagnosis and intervention. Eur Child Adolesc Psychiatry 13:80-92.
87. Gould TD, Manji HK. 2004. The molecular medicine revolution and psychiatry: bridging the gap between basic neuroscience research and clinical psychiatry. J Clin Psychiatry 65:598-604.
88. Gross-Isseroff R, Luca-Haimovici K, Sasson Y, Kindler S, Kotler M, Zohar J. 1994. Olfactory sensitivity in major depressive disorder and obsessive compulsive disorder. Biol Psychiatry 35:798-802.
89. Hagenah J, Konig IR, Sperner J, Wessel L, Seidel G, Condefer K, et al. 2010. Life-long increase of substantia nigra hyperechogenicity in transcranial sonography. Neuroimage 51:28-32.
90. Hal á sz M, Shepherd GM. 1983. Neurochemistry of the vertebrate olfactory bulb. Neuroscience 10:579-619.
91. Hartsough CS, Lambert NM. 1985. Medical factors in hyperactive and normal children: prenatal, developmental, and health history findings. Am J Orthopsychiatry 55:190-201.
92. Hegde PS, White IR, Debouck C. 2003. Interplay of transcriptomics and proteomics. Curr Opin Biotechnol 14:647-651.
93. Herrmann MJ, Saathoff C, Schreppel TJ, Ehlis AC, Scheuerpfl ug P, Pauli P, Fallgatter AJ. 2009. The effect of ADHD symptoms on performance monitoring in a non-clinical population. Psychiatry Res 169:144-148.
94. Herrmann MJ, Mader K, Schreppel T, Jacob C, Heine M, Boreatti-Hümmer A, et al. 2010. Neural correlates of performance monitoring in adult patients with attention deficit hyperactivity disorder (ADHD). World J Biol Psychiatry 11:457-464.
95. Hirano M, Rakwal R, Shibato J, Sawa H, Nagashima K, Ogawa Y, et al. 2008. Proteomics-and transcriptomics-based screening of differentially expressed proteins and genes in brain of Wig rat: a model for attention deficit hyperactivity disorder (ADHD) research. J Proteome Res 7:2471-2489.
96. Hollingsworth DE, McAuliffe SP, Knowlton BJ. 2001. Temporal allocation of visual attention in adult attention deficit hyperactivity disorder. J Cogn Neurosci 13:298-305.
97. Homack S, Riccio CA. 2004. A meta-analysis of the sensitivity and specificity of the Stroop Color and Word Test with children. Arch Clin Neuropsychol 19:725-743.
98. Horton AM Jr. 1996. Neuropsychological findings in adult attention deficit disorder: a pilot study. Appl Neuropsychol 3:181-183.
99. Hsia AY, Vincent JD, Lledo PM. 1999. Dopamine depresses synaptic inputs into the olfactory bulb. J Neurophysiol 82: 1082-1085.
100. Huisman E, Uylings H, Hoogland P. 2004. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Move Disord 19:687-692.
101. Hynd GW, Hern KL, Novey ES, Eliopulos D, Marshall R, Gonzalez JJ, Voeller KK. 1993. Attention deficit-hyperactivity disorder and asymmetry of the caudate nucleus. J Child Neurol 8:339-347.
102. Ivanov I, Bansal R, Hao X, Zhu H, Kellendonk C, Miller L, et al. 2010. Morphological abnormalities of the thalamus in youths with attention deficit hyperactivity disorder. Am J Psychiatry 167:397-408.
103. Jacob CP, Romanos J, Dempfl e A, Heine M, Windemuth-Kieselbach C, Kruse A, et al. 2007. Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center. Eur Arch Psychiatry Clin Neurosci 257:309-317.
104. Jenkins M, Cohen R, Malloy P, Salloway S, Johnson EG, Penn J, et al. 1998. Neuropsychological measures which discriminate among adults with residual symptoms of attention deficit disorder and other attentional complaints. Clin Neuropsychol 12: 74-83.
105. Jonkman LM, Kemner C, Verbaten MN, Van Engeland H, Kenemans JL, Camfferman G, et al. 1999. Perceptual and response interference in children with attention-deficit hyperactivity disorder, and the effects of methylphenidate. Psychophysiology 36:419-429.
106. Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L. 2005. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: Association between striatal dopamine markers and motor hyperactivity. Biol Psychiatry 57:229-238.
107. Kaplan BJ, Dewey D, Crawford SG, Fisher GC. 1998. Deficits in long-term memory are not characteristic of ADHD. Attention Deficit Hyperactivity Disorder. J Clin Exp Neuropsychol 20:518-528.
108. Kareken DA, Mosnik DM, Doty RL, Dzemidzic M, Hutchins GD. 2003. Functional anatomy of human odor sensation, discrimination, and identification in health and aging. Neuropsychology 17:482-495.
109. Karsz FR, Vance A, Anderson VA, Brann PG, Wood SJ, Pantelis C, Brewer WJ. 2008. Olfactory impairments in child attentiondeficit/hyperactivity disorder. J Clin Psychiatry 69:1462-1468.
110. Khan AU, Dekirmenjian H. 1981. Urinary excretion of catecholamine metabolites in hyperkinetic child syndrome. Am J Psychiatry 138:108-110.
111. Kiive E, Merenäkk L, Harro M, Harro J. 2005. Changes in platelet monoamine oxidase activity, cholesterol levels and hyperactive behaviour in adolescents over a period of three years. Neurosci Lett 384:310-315.
112. Kissling C, Retz W, Wiemann S, Coogan AN, Clement RM, H ü nnerkopf R, et al. 2008. A polymorphism at the 3 '-untranslated region of the CLOCK gene is associated with adult attentiondeficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147:333-338.
113. Klingberg T, Fernell E, Olesen PJ, Johnson M, Gustafsson P, Dahlström K, et al. 2005. Computerized training of working memory in children with ADHD-a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 44:177-186.
114. Kopecková M, Paclt I, Petrásek J, Pacltová D, Malíková M, Zagatová V. 2008. Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6-10 age. Neuro Endocrinol Lett 29:246-251.
115. Konrad K, Neufang S, Hanisch Fink GR, Herpertz-Dahlmann B. 2006. Dysfunctional attentional networks in children with attention deficit/hyperactivity disorder: Evidence from an event-related functional magnetic resonance imaging study. Biol Psychiatry 59:643-651.
116. Konrad K, Eickhoff SB. 2010. Is the ADHD brain wired differently? A review on structural and functional connectivity in attention deficit hyperactivity disorder. Hum Brain Mapp 31:904-916.
117. Koutsouleris N, Meisenzahl EM, Davatzikos C, Bottlender R, Frodl T, Scheuerecker J, et al. 2009. Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry 66:700-712.
118. Kovalev VV. 1975. Borderline states of intellectual deficiency in children. In: Primrose DAA, editor. Proceedings of the Third Congress of the International Association of the Scientific Study of Mental Deficirncy. Warsaw: Polish Medical Publishers. p 103-108.
119. Kovner R, Budman C, Frank Y, Sison C, Lesser M, Halperin J. 1998. Neuropsychological testing in adult attention deficit hyperactivity disorder: a pilot study. Int J Neurosci 96: 225-235.
120. Krasov VA. 1988. Sydnocarb treatment of junior school age children with hyperdynamic syndrome. Zh Nevrol Psychiatr SS Korsakova 88:97-101.
121. Krauel K, Duzel E, Hinrichs H, Santel S, Rellum T, Baving L. 2007. Impact of emotional salience on episodic memory in attention-deficit/hyperactivity disorder: a functional magnetic resonance imaging study. Biol Psychiatry 61:1370-1379.
122. Krauel K, Feldhaus HC, Simon A, Rehe C, Glaser M, Flechtner HH, et al. 2010. Increased echogenicity of the substantia nigra in children and adolescents with attention-deficit/hyperactivity disorder. Biol Psychiatry 68:352-358.
123. LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, Kennedy JL. 1996. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1:121-124.
124. Lange KW, Tucha L, Walitza S, Gerlach M, Linder M, Tucha O. 2007. Interaction of attention and graphomotor functions in children with attention deficit hyperactivity disorder. J Neural Transm Suppl 72:249-259.
125. Lapin IP. 2004. Stress-anxiety-depression-alcoholizm-epilepsy. (Neurokynine mechanisms and new approaches to the treatment. St Peterburg: Dean.
126. Lapin IP, Mizaev S, Prakh ' e IB, Ryzhkov IV. 1991. Kynurenine protection against ethanol-induced disorders of burrowing refl ex in mice and rats. Zh Vyssh Nerv Deiat IP Pavlova 41: 551-556.
127. Lawrence V, Houghton S, Douglas G, Durkin K, Whiting K, Tannock R. 2004. Executive function and ADHD: a comparison of children's performance during neuropsychological testing and real-world activities. J Attent Disord 7:137-149.
128. Lenroot RK, Gogtay N, Greenstein DK, Wells EM, Wallace GL, Clasen LS, et al. 2007. Sexual dimorphism of brain developmental trajectories during childhood and adolescence. Neuroimage 36:1065-1073.
129. Lesch KP, Timmesfeld N, Renner TJ, Halperin R, Röser C, Nguyen TT, et al. 2008. Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm 115:1573-1585.
130. Levy F, Hay DA, McStephen M, Wood C, Waldman I. 1997. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 36:737-744.
131. Lezak MD, Howieson DB, Loring DW. 2004. Neuropsychological Assessment. 4th ed. New York: Oxford University Press.
132. Llorente AM, Voigt RG, Jensen CL, Berretta MC, Kennard Fraley J, Heird WC. 2006. Performance on a visual sustained attention and discrimination task is associated with urinary excretion of norepinephrine metabolite in children with attentiondeficit/hyperactivity disorder (AD/HD). Clin Neuropsychol 20: 133-144.
133. Lombion-Pouthier S, Vandel P, Nezelof S, Haffen E, Millot JL. 2006. Odor perception in patients with mood disorders. J Affect Disord 90:187-91.
134. Lorch EP, Milich R, Flake RA, Ohlendorf J, Little S. 2010. A developmental examination of story recall and coherence among children with ADHD. J Abnorm Child Psychol 38: 291-301.
135. Losier BJ, McGrath PJ, Klein RM. 1996. Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review. J Child Psychol Psychiatry 37:971-987.
136. Lovejoy DW, Ball JD, Keats M, Stutts ML, Spain EH, Janda L, Janusz J. 1999. Neuropsychological performance of adults with attention deficit hyperactivity disorder (ADHD): diagnostic classification estimates for measures of frontal lobe/executive functioning. J Int Neuropsychol Soc 5:222-233.
137. Ludolph AG, Kassubek J, Schmeck K, Glaser C, Wunderlich A, Buck AK, et al. 2008. Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-18Ffl uorophenyl-l-alanine PET study. Neuroimage 41:718-727.
138. Mackie S, Shaw P, Lenroot R, Pierson R, Greenstein DK, Nugent TF 3rd, et al. 2007. Cerebellar development and clinical outcome in attention deficit hyperactivity disorder. Am J Psychiatry 164:647-655.
139. Maiya R, Ponomarev I, Linse KD, Harris RA, Mayfield RD. 2007. Defining the dopamine transporter proteome by convergent biochemical and in silico analyses. Genes Brain Behav 6:97-106.
140. Mandi Y, Vecsei L. 2012. The kynurenine system and immunoregulation. J Neural Transm 119:197-209.
141. Manly T, Anderson V, Nimmo-Smith I, Turner A, Watson P, Robertson IH. 2001. The differential assessment of children's attention: the Test of Everyday Attention for Children (TEA-Ch), normative sample and ADHD performance. J Child Psychol Psychiatry 42:1065-1081.
142. Martinussen R, Hayden J, Hogg-Johnson S, Tannock R. 2005. A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 44:377-384.
143. McClure SM, Laibson DI, Loewenstein G, Cohen JD. 2004. Separate neural systems value immediate and delayed monetary rewards. Science 306:503-507.
144. Mehler-Wex C, Riederer P, Gerlach M. 2006. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson ́ s disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox Res 10: 167-179.
145. Mesholam RI, Moberg PJ, Mahr RN, Doty RL. 1998. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol 55:84-90.
146. Mikkelsen E, Lake CR, Brown GL, Ziegler MG, Ebert MH. 1981. The hyperactive child syndrome: peripheral sympathetic nervous system function and the effect of d-amphetamine. Psychiatry Res 4:157-169.
147. Miller CJ, Flory JD, Miller SR, Harty SC, Newcorn JH, Halperin JM. 2008. Childhood attention-deficit/hyperactivity disorder and the emergence of personality disorders in adolescence: a prospective follow-up study. J Clin Psychiatry. 69:1477-1484.
148. Moberg PJ, Arnold SE, Doty RL, Gur RC, Balderston CC, Roalf DR, et al. 2006. Olfactory functioning in schizophrenia: relationship to clinical, neuropsychological, and volumetric MRI measures. J Clin Exp Neuropsychol 28:1444-1461.
149. Moll GH, Heinrich H, Trott G, Wirth S, Rothenberger A. 2000. Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate. Neurosci Lett 284:121-125.
150. Muir-Broaddus JE, Rosenstein LD, Medina DE, Soderberg C. 2002. Neuropsychological test performance of children with ADHD relative to test norms and parent behavioral ratings. Arch Clin Neuropsychol 17:671-689.
151. Murphy KC, Barkley R, Bush T 2001. Executive functioning and olfactory identification in young adults with attention deficithyperactivity disorder. Neuropsychology 15:211-20.
152. Oades RD. 2000. Differential measures of "sustained attention" in children with attention-deficit/hyperactivity or tic disorders: relation to monoamine metabolism. Psychiatry Res 93:165-78.
153. Oades RD, Sadile AG, Sagvolden T, Viggiano D, Aase H, Zuddas A, et al. 2005. The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic, and interactive roles. Dev Sci 8:122-131.
154. Oldiges M, L ü tz S, Pfl ug S, Schroer K, Stein N, Wiendahl C. 2007. Metabolomics: current state and evolving methodologies and tools. Appl Microbiol Biotechnol 76:495-511.
155. Peterson BS, Potenza MN, Wang Z, Zhu H, Martin A, Marsh R, et al. 2009. An FMRI study of the effects of psychostimulants on default-mode processing during Stroop task performance in youths with ADHD. Am J Psychiatry 166:1286-1294.
156. Plailly J, Radnovich AJ, Sabri M, Royet JP, Kareken DA. 2007. Involvement of the left anterior insula and frontopolar gyrus in odor discrimination. Hum Brain Mapp 28:363-372.
157. Plessen KJ, Bansal R, Zhu H, Whiteman R, Amat J, Quackenbush GA, et al. 2006. Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 63:795-807.
158. Pliszka SR, Maas JW, Javors MA, Rogeness GA, Baker J. 1994. Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 33:1165-1173.
159. Pliszka SR, Liotti M, Woldorff MG. 2000. Inhibitory control in children with attention-deficit/hyperactivity disorder: eventrelated potentials identify the processing component and timing of an impaired right-frontal response-inhibition mechanism. Biol Psychiatry 48:238-246.
160. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. 2007. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164:942-948.
161. Pollak Y, Kahana-Vax G, Hoofien D. 2008. Retrieval processes in adults with ADHD: a RAVLT study. Dev Neuropsychol 33: 62-73.
162. Pollatos O, Albrecht J, Kopietz R, Linn J, Schoepf V, Kleemann AM, et al. 2007. Reduced olfactory sensitivity in subjects with depressive symptoms. J Affect Disord 102:101-108.
163. Qiu A, Crocetti D, Adler M, Mahone EM, Denckla MB, Miller MI, et al. 2009. Basal ganglia volume and shape in children with attention deficit hyperactivity disorder. Am J Psychiatry 166:74-82.
164. Quinlan DM, Brown TE. 2003. Assessment of short-term verbal memory impairments in adolescents and adults with ADHD. J Attent Disord 6:143-152.
165. Richter MM, Ehlis AC, Jacob CP, Fallgatter AJ. 2007. Cortical excitability in adult patients with attention-deficit/hyperactivity disorder (ADHD). Neurosci Lett 419:137-141.
166. Rogeness GA, Maas JW, Javors MA, Macedo CA, Fischer C, Harris WR. 1989. Attention deficit disorder symptoms and urine catecholamines. Psychiatry Res 27:241-251.
167. Rolfe MH, Hamm JP, Waldie KE. 2008. Differences in paperand-pencil versus computerized line bisection according to ADHD subtype and hand-use. Brain Cogn 66:188-195.
168. Romanos M, Renner TJ, Schecklmann M, Hummel B, Roos M, von Mering C, et al. 2008. Improved odor sensitivity in attentiondeficit/hyperactivity disorder. Biol Psychiatry 64:938-940.
169. Romanos M, Weise D, Schliesser M, Schecklmann M, Loffl er J, Warnke A, et al. 2010. Structural abnormality of the substantia nigra in children with attention-deficit hyperactivity disorder. J Psychiatry Neurosci 35:55-58.
170. Rubi B, Maechler P. 2010. Minireview: new roles for peripheral dopamine on metabolic control and tumor growth: let's seek the balance. Endocrinology 151:5570-5581.
171. Rubia K, Smith A. 2001. Attention deficit-hyperactivity disorder: current findings and treatment. Curr Opin Psychiatry 14: 309-316.
172. Rubia K, Halari R, Cubillo A, Mohammad AM, Scott S, Brammer M. 2009a. Disorder-specific inferior prefrontal hypofunction in boys with pure attention-deficit/hyperactivity disorder compared to boys with pure conduct disorder during cognitive fl exibility. Hum Brain Mapp 31:287-299.
173. Rubia K, Halari R, Cubillo A, Mohammad AM, Brammer M, Taylor E. 2009b. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naive children with ADHD during a rewarded continuous performance task. Neuropharmacology 57:640-652.
174. Sami N, Carte ET, Hinshaw SP, Zupan BA. 2003. Performance of girls with ADHD and comparison girls on the Rey-Osterrieth Complex Figure: evidence for executive processing deficits. Child Neuropsychol 9:237-254.
175. Savic I, Gulyas B, Larsson M, Roland P. 2000. Olfactory functions are mediated by parallel and hierarchical processing. Neuron 26:735-745.
176. Savic I, Gulyas B, Berglund H. 2002. Odorant differentiated pattern of cerebral activation: comparison of acetone and vanillin. Hum Brain Mapp 17:17-27.
177. Schecklmann M, Ehlis AC, Plichta MM, Fallgatter AJ. 2008a. Functional near-infrared spectroscopy: a long-term reliable tool for measuring brain activity during verbal fl uency. Neuroimage 43:147-155.
178. Schecklmann M, Ehlis AC, Plichta MM, Romanos J, Heine M, Boreatti-Hümmer, A et al. 2008b. Diminished prefrontal oxygenation with normal and above-average verbal fl uency performance in adult ADHD. J Psychiatr Res 43:98-106.
179. Schecklmann M, Schenk E, Maisch A, Kreiker S, Jacob C, Warnke A, et al. 2010. Altered frontal and temporal brain function during olfactory stimulation in adult attention-deficit/hyperactivity disorder. Neuropsychobiology 63:66-76.
180. Schneider M, Retz W, Coogan A, Thome J, Rösler M. 2006. Anatomical and functional brain imaging in adult attentiondeficit/hyperactivity disorder (ADHD). A neurological view. Eur Arch Psychiatry Clin Neurosci 258:192-193.
181. Schreder T, Albrecht J, Kleemann AM, Schöpf V, Kopietz R, Anzinger A, et al. 2008. Olfactory performance of patients with anorexia nervosa and healthy subjects in hunger and satiety. Rhinology 46:175-183.
182. Schreiber HE, Javorsky DJ, Robinson JE, Stern RA. 1999. Rey-Osterrieth Complex Figure performance in adults with attention deficit hyperactivity disorder: a validation study of the Boston Qualitative Scoring System. Clin Neuropsychol 13:509-520.
183. Schweitzer JB, Faber TL, Grafton ST, Tune LE, Hoffman JM, Kilts CD. 2000. Alterations in the functional anatomy of working memory in adult attention deficit hyperactivity disorder. Am J Psychiatry 157:278-280.
184. Seidman LJ, Biederman J, Weber W, Hatch M, Faraone SV. 1998. Neuropsychological function in adults with attention-deficit hyperactivity disorder. Biol Psychiatry 44:260-268.
185. Sergeant JA, Geurts H, Oosterlaan J. 2002. How specific is a deficit of executive functioning for attention-deficit/hyperactivity disorder? Behav Brain Res 130:3-28.
186. Shaw LM, Korecka M, Clark CM, Lee V M-Y, Trojanowski JQ. 2007. Biomarkers of neurodegeration for diagnosis and monitoring therapeutics. Nat Rev 6:295-303.
187. Shaw P, Greenstein D, Lerch J, Clasen L, Lenroot R, Gogtay N, et al. 2006. Intellectual ability and cortical development in children and adolescents. Nature 440:676-679.
188. Shaw P, Eckstrand K, Sharp W, Blumenthal J, Lerch JP, Greenstein D, et al. 2007. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci USA 104:19649-19654.
189. Shaw P, Lalonde F, Lepage C, Rabin C, Eckstrand K, Sharp W, et al. 2009. Development of cortical asymmetry in typically developing children and its disruption in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 66:888-896.
190. Shekim WO, Dekirmenjian H, Chapel JL. 1978. Urinary MHPG excretion in the hyperactive child syndrome and the effects of dextroamphetamine. Psychopharcol Bull 14:42-44.
191. Shekim WO, Javaid J, Dekirmenjian H, Chapel JL, Davis JM. 1982. Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys. Am J Psychiatry 139:485-488.
192. Sheppard DM, Bradshaw JL, Mattingley JB, Lee P. 1999. Effects of stimulant medication on the lateralisation of line bisection judgements of children with attention deficit hyperactivity disorder. J Neurol Neurosurg Psychiatry 66:57-63.
193. Shiels K, Hawk LW Jr. 2010. Self-regulation in ADHD: the role of error processing. Clin Psychol Rev 30:951-961.
194. Shue KL, Douglas VI. 1992. Attention deficit hyperactivity disorder and the frontal lobe syndrome. Brain Cogn 20:104-124.
195. Slaats-Willemse D. 2003. Cognitive Endophenotypes of ADHD. Wageningen: Ponsen and Looijen BV.
196. Slaats-Willemse DI, Swaab-Barneveld HJ, de Sonneville LM, Buitelaar JK. 2007. Family-genetic study of executive functioning in attention-deficit/ hyperactivity disorder: Evidence for an endophenotype? Neuropsychology 21:751-760.
197. Sommer U, Hummel T, Cormann K, Mueller A, Frasnelli J, Kropp J, Reichmann H. 2004. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT. Move Disord 19:1196-202.
198. Sonuga-Barke EJ. 2003. The dual-pathway model of AD/HD: an elaboration of neuro-developmental characteristics. Neurosci Biobehav Rev 27:593-604.
199. Sonuga-Barke EJ, Castellanos FX. 2007. Spontaneous attentional fl uctuations in impaired states and pathological conditions: a neurobiological hypothesis. Neurosci Biobehav Rev 31:977-986.
200. Spiegel J, Hellwig D, Mollers MO, Behnke S, Jost W, Fassbender K, et al. 2006. Transcranial sonography and 123IFP-CIT SPECT disclose complementary aspects of Parkinson's disease. Brain 129:1188-1193.
201. Stergiakouli E, Thapar A. 2010. Fitting the pieces together: current research on the genetic basis of attention-deficit/hyperactivity disorder (ADHD). Neuropsychiatr Dis Treat 6:551-560.
202. Taurines R, Schmitt J, Renner T, Conner AC, Warnke A, Romanos M. 2010a. Developmental comorbidity in attention-deficit/hyperactivity disorder. Attent Def Hyp Disord 2:267-289.
203. Taurines R, Dudley E, Conner AC, Grassl J, Jans T, Guderian F, et al. 2010b. Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry. Eur Arch Psychiatry Clin Neurosci. 260:249-255.
204. Taurines R, Dudley E, Grassl J, Warnke A, Gerlach M, Coogan AN, Thome J. 2011a. Proteomic research in psychiatry. J Psychopharmacol 25:151-196 (Review).
205. Taurines R, Grünblatt E, Schecklmann M, Schwenk C, Albantakis L, Reefschläger L, et al. 2011b. Altered mRNA expression of monoaminergic candidate genes in the blood of attention deficit hyperactivity disorder and autism spectrum disorder. World J Biol Psychiatry 12 (Suppl. 1):104-108.
206. Taylor E, Doepfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, et al. 2004. European Clinical Guidelines for Hyperkinetic Disorder-first update. Eur Child Adolesc Psychiatry 13:7-30.
207. The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group. 1998. Consensus report of the Working Group on: Molecular and Biochemical Markers of Alzheimer's Disease. Neurobiol Aging 19:109-116.
208. Thome J, Reddy DP. 2009. The current status of research into attention deficit hyperactivity disorder. Proceedings of the 2nd International Congress on ADHD: from childhood to adult. ADHD Attentt Def Hyp Disord 1:165-174.
209. Tucha O, Lange KW. 2001. Effects of methylphenidate on kinematic aspects of handwriting in hyperactive boys. J Abnorm Child Psychol 29:351-356.
210. Tucha O, Prell S, Mecklinger L, Bormann-Kischkel C, K ü bber S, Linder M, Walitza S, Lange KW. 2006a. Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder. Psychopharmacology 185:315-326.
211. Tucha O, Walitza S, Mecklinger L, Sontag TA, K ü bber S, Linder M, Lange KW. 2006b. Attentional functioning in children with ADHD-predominantly hyperactive-impulsive type and children with ADHD-combined type. J Neural Transm 113: 1943-1953.
212. Tucha L, Tucha O, Laufkötter R, Walitza S, Klein HE, Lange KW. 2008. Neuropsychological assessment of attention in adults with different subtypes of attention-deficit/hyperactivity disorder. J Neural Transm 115:269-278.
213. Tucha L, Tucha O, Walitza S, Sontag TA, Laufkötter R, Linder M, Lange KW. 2009. Vigilance and sustained attention in children and adults with ADHD. J Attent Disord 12:410-421.
214. Tucha L, Tucha O, Sontag TA, Stasik D, Laufkötter R, Lange KW. 2011. Differential Effects of Methylphenidate on Problem Solving in Adults With ADHD. J Attent Disord 15:161-173.
215. Uzbekov MG. 2006. The hyperkinetic syndrome as a manifestation of a developmental disturbances of brain monoaminergic systems. In: Oades RD, editor. Attention Deficit/Hyperactivity Disorder (AD/HD) and the Hyperkinetic Syndrome (HKS): current ideas and ways forward. New York: Nova Scientific Publishers. p. 133-154.
216. Uzbekov MG, Misionzhnik EY. 2003. Changes in urinary monoamine excretion in hyperkinetic children. Hum Psychopharmacol Clin Exp 18:493-497.
217. Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH, Gabrieli JD. 1998. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci USA 95:14494-14499.
218. Valera EM, Faraone SV, Murray KE, Seidman LJ. 2007. Metaanalysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry 61:1361-1369.
219. Vamos E, Pardutz A, Klivenyi P, Toldi J, Vecsei L. 2009. The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection. J Neurol Sci 283:21-27.
220. van Mourik R, Oosterlaan J, Sergeant JA. 2005. The Stroop revisited: a meta-analysis of interference control in AD/HD. J Child Psychol Psychiatry 46:150-165.
221. van Zomeren AH, Brouwer WH. 1994. Clinical neuropsychology of attention. New York: Oxford University Press.
222. Volkow ND, Wang GJ, Newcorn J, Fowler JS, Telang F, Solanto MV, et al. 2007. Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage 34:1182-1190.
223. Volkow ND, Fowler JS, Wang GJ, Telang F, Logan J, Wong C, et al. 2008. Methylphenidate decreased the amount of glucose needed by the brain to perform a cognitive task. PLoS ONE 3:e2017.
224. Voloshina ON, Moskvitina TA. 1985. Method of estimation of platelet monoamine oxidase activity. Lab Delo 5:56-65.
225. Walter U, Behnke S, Eyding J, Niehaus L, Postert T, Seidel G, et al. 2007. Transcranial brain parenchyma sonography in movement disorders: state of the art. Ultrasound Med Biol 33:15-25.
226. Wassenberg R, Hendriksen JG, Hurks PP, Feron FJ, Vles JS, Jolles J. 2010. Speed of language comprehension is impaired in ADHD. J Attent Disord 13:374-385.
227. Weissman DH, Roberts KC, Visscher KM, Woldorff MG. 2006. The neural bases of momentary lapses in attention. Nat Neurosci 9:971-978.
228. Wender P. 1971. Minimal Brain Dysfunction in Children. New York: Wiley-Interscience.
229. Westerberg H, Hirvikoski T, Forssberg H., Klingberg T. 2004. Visuo-spatial working memory span: a sensitive measure of cognitive deficits in children with ADHD. Child Neuropsychol 10:155-161.
230. Weyandt LL, Rice JA, Linterman I, Mitzlaff L, Emert E. 1998. Neuropsychological perforamance of a sample of adults with ADHD, developmental reading disorder, and controls. Dev Neuropsychol 14:643-656.
231. Whitman MC, Greer CA. 2009. Adult neurogenesis and the olfactory system. Progr Neurobiol. 89:162-175.
232. Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. 2005. Validity of the executive function theory of attentiondeficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry 57:1336-1346.
233. Williams C, Wright B, Partridge I. 1999. Attention deficit hyperactivity disorder-a review. Br J Gen Pract 49:563-571.
234. Winner B, Geyer M, Couillard-Despres S, Aigner R, Bogdahn U, Aigner L, et al. 2006. Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol 197:113-121.
235. World Health Organization. 1992. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization.
236. Yong-Liang G, Robaey P, Karayanidis F, Bourassa M, Pelletier G, Geoffroy G. 2000. ERPs and behavioural inhibition in a Go/No-go task in children with attention-deficit hyperactivity disorder. Brain Cogn 43:215-220.
237. Zadori D, Klivenyi P, Plangar I, Toldi J, Vecsei L. 2011. Endogenous neuroprotection in chronic neurodegenerative disorders with particular regard to the kynurenines. J Cell Mol Med 15:701-717.
238. Zecca L, Berg D, Arzberger T, Ruprecht P, Rausch WD, Musicco M, et al. 2005. In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Move Disord 20: 1278-1285.